Suppr超能文献

异基因造血干细胞移植患者感染 2009 年 H1N1 流感的临床特征和转归:英国血液和骨髓移植学会研究。

The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study.

机构信息

Bristol Adult Bone Marrow Transplant Unit, University Hospitals Bristol, Bristol, UK.

出版信息

Bone Marrow Transplant. 2012 Jan;47(1):88-94. doi: 10.1038/bmt.2011.12. Epub 2011 Feb 28.

Abstract

The clinical course of 2009 H1N1 influenza in Allo-SCT patients is unknown. Data were collected in the UK from October 2009 to April 2010 on laboratory-confirmed cases of H1N1 influenza in Allo-SCT recipients. H1N1 infection was diagnosed in 60 patients, median age 42 years, at a median of 10 months post-SCT. Twenty-one patients (35%) developed pneumonia and nine (15%) required admission to intensive care units. Actuarial mortality was 7% at 28 days and 19% 4 months post-diagnosis of 2009 H1N1 influenza. Increasing age and pre-existing lung disease were risk factors for pneumonia (P=0.006 and 0.037, respectively); older age was a risk factor for death (P=0.012). Morbidity and mortality from 2009 H1N1 influenza in SCT patients exceeds that of immunocompetent patients, but parallels that in other critically ill hospitalised cohorts; the elderly and those with chronic pulmonary disease are at greatest risk.

摘要

异基因造血干细胞移植(Allo-SCT)患者中 2009 年 H1N1 流感的临床病程尚不清楚。2009 年 10 月至 2010 年 4 月,英国对 Allo-SCT 受者实验室确诊的 H1N1 流感病例进行了数据收集。在 60 例确诊为 H1N1 感染的患者中,中位年龄为 42 岁,中位时间为移植后 10 个月。21 例(35%)患者发生肺炎,9 例(15%)需要入住重症监护病房。28 天和 4 个月时,H1N1 流感的累积死亡率分别为 7%和 19%。年龄增加和预先存在的肺部疾病是发生肺炎的危险因素(P=0.006 和 0.037);年龄较大是死亡的危险因素(P=0.012)。造血干细胞移植患者的 2009 年 H1N1 流感发病率和死亡率高于免疫功能正常的患者,但与其他重症住院患者队列相似;年龄较大和患有慢性肺部疾病的患者风险最大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验